Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03414905 · ClinicalTrials.gov registry record

Management of Malignant Pleural Effusions Using an Indwelling Tunneled Pleural Catheter and Non-Vacuum Collection System

A clinical trial, sponsored by Washington University School of Medicine.

Completed
Registry status
40
Enrollment target

NCT03414905: Completed study, sponsored by Washington University School of Medicine.

NCT03414905 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03414905 has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
40 participants
Enrollment target

Study Summary

In this study, the investigators will collect data on patients who are using the Aspira system as part of their clinical care for the management of recurrent pleural effusion. Data will be collected on patient demographics, placement of the pleural catheter, palliation of dyspnea, complication rates, and rates of spontaneous pleurodesis.

Primary Outcome

* This will be determined based on the difference between the VAS-Dyspnea score on the day of catheter insertion prior to catheter insertion compared with the VAS-Dyspnea score on the 2 week follow up visit * The scale presents the question "how much shortness of breath are you having right now?" with a straight line. At one end it states "no shortness of breath" and the other end is "shortness of breath as bad as can be". The participant will mark the line on how they feel * No shortness is bre

Interventions

  • PROCEDURE Ultrasound
  • DEVICE Aspira Catheter

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-07-09
Est. Completion 2024-02-15

What the finished NCT03414905 record still lists

NCT03414905 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Ultrasound is the first listed.

NCT03414905 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03414905 about?

NCT03414905 is a clinical study titled "Management of Malignant Pleural Effusions Using an Indwelling Tunneled Pleural Catheter and Non-Vacuum Collection System". In this study, the investigators will collect data on patients who are using the Aspira system as part of their clinical care for the management of recurrent pleural effusion. Data will be collected on patient demographics, placement of the pleural catheter, palliation of dyspnea, complication rates...

What is the current status of trial NCT03414905?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-07-09. Estimated completion is 2024-02-15.

What interventions are being tested in trial NCT03414905?

The interventions under investigation include: Ultrasound (PROCEDURE), Aspira Catheter (DEVICE).

Who is sponsoring clinical trial NCT03414905?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03414905, the US trial registry maintained by the National Library of Medicine. NCT03414905 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.